1-5 of 5
Hugh J.B. Goodman
Close
Sort by
Journal Articles

Standard Oral Melphalan Chemotherapy for AL Amyloidosis Revisited Using the Serum Free Light Chain Assay.

Mark Offer, Ashutosh D. Wechalekar, Hugh J.B. Goodman, Julian D. Gillmore, Helen J. Lachmann, Arthur R. Bradwell, Philip N. Hawkins
Journal: Blood
Blood (2005) 106 (11): 3495.
https://doi.org/10.1182/blood.V106.11.3495.3495
Published: 2005
Journal Articles

Efficacy of Risk Adapted Cyclophosphamide, Thalidomide and Dexamethasone in Systemic AL Amyloidosis.

Ashutosh D. Wechalekar, Hugh J.B. Goodman, Julian D. Gillmore, Helen J. Lachmann, Mark Offer, Arthur R. Bradwell, Philip N. Hawkins
Journal: Blood
Blood (2005) 106 (11): 3496.
https://doi.org/10.1182/blood.V106.11.3496.3496
Published: 2005
Journal Articles

The Role of Renal Transplantation in Systemic AL Amyloidosis.

Ashutosh D. Wechalekar, Helen J. Lachmann, Julian D. Gillmore, Hugh J.B. Goodman, Mark Offer, Philip N. Hawkins
Journal: Blood
Blood (2005) 106 (11): 3497.
https://doi.org/10.1182/blood.V106.11.3497.3497
Published: 2005
Journal Articles

Clinical Profile and Treatment Outcome in 92 Patients with AL Amyloidosis Associated with IgM Paraproteinaemia.

Ashutosh D. Wechalekar, Hugh J.B. Goodman, Julian D. Gillmore, Helen J. Lachmann, Mark Offer, Arthur R. Bradwell, Philip N. Hawkins
Journal: Blood
Blood (2005) 106 (11): 3498.
https://doi.org/10.1182/blood.V106.11.3498.3498
Published: 2005
Journal Articles

Intermediate Dose Intravenous Melphalan and Dexamethasone Treatment in 144 Patients with Systemic AL Amyloidosis.

Hugh J.B. Goodman, FRACP FRCPA, Helen J. Lachmann, MD MRCP, Arthur R. Bradwell, FRCP FRCPath, Philip N. Hawkins, PhD FRCP
Journal: Blood
Blood (2004) 104 (11): 755.
https://doi.org/10.1182/blood.V104.11.755.755
Published: 2004